StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by JHendrixon May 30, 2020 8:04am

171 Views

Post# 31091359

Omg, posting thru the night

Geez, all the posting won't create a fireball Monday, nor save SZLS from Tripp. Tripp probably had a very sound sleep, even with this weekend conference.
its now clear to me that the big players don't trust Tripp, or his track record or his being overly optimistic.
Tripp needs to release the numbers for Covid tests, and bulous revenue.
Get some sleep. Let's see what happens Monday morning.

Bullboard Posts

Global Tungsten Market and Supply Security